Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the Moderna COVID-19 Vaccine across Central Eastern...

INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals Suzhou Co., Ltd....

Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM

Following today’s U.S. FDA accelerated approval of ADUHELMTM  as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain, Biogen  and Eisai Inc., U.S. subsidiary of...

Pacira BioSciences, Inc. partners with Ashfield Engage to deliver European commercial infrastructure

Ashfield Engage, part of UDG Healthcare plc, announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for its non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to...

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics, the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel multifunctional immune-recruitment proteins. Under the terms of the agreement, Samsung Biologics will provide its end-to-end...

ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain

Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India...

Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

Pfizer Inc and BioNTech SE  announced that the Conditional Marketing Authorization (CMA) for COMIRNATY® in the European Union (EU) has been expanded to include individuals 12 to 15 years of age. This follows the European Medicines Agency’s (EMA) Committee...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »